John P. Richard

John P. Richard has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Gyre Therapeutics, Inc. and Vaxart, Inc. Over a trading history stretching from 1 February 2007 to 13 March 2020, the count stands at 17 filings.

Market trades split into 4 purchases (€48k) and 5 sales (€403k). Netting one side against the other leaves €355k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 7 option exercises. So far in 2020, the count stands at 1 purchase and no sales.

Half of the purchases are above €8,038 and half below. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -2.7%. This is a record of the past, not a forecast.

The record was last updated on 13 March 2020 with an open-market purchase (€8,896) in Gyre Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.